AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32891278 — intervention group
Group type: EXPERIMENTAL
Intervention: Peppermint essential oil inhalation
Number of subjects: 60
Study 32891278 — intervention group
Group type: COMPARATOR
Intervention: Control (no peppermint essential oil)
Number of subjects: 60
Study 35943609 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing nursing care team mode
Number of subjects: 100
Study 35943609 — intervention group
Group type: COMPARATOR
Intervention: Traditional telephone follow-up mode
Number of subjects: 100
Study 33605981 — intervention group
Group type: EXPERIMENTAL
Intervention: Village doctor‐led multifaceted intervention
Number of subjects: 33995
Study 33605981 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 33995
Study 34387661 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat (26.3°C)
Number of subjects: 14991
Study 34387661 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold
Number of subjects: 14991
Study 34431972 — intervention group
Group type: EXPERIMENTAL
Intervention: Telepsychiatry collaborative care (TCC)
Number of subjects: 1004
Study 34431972 — intervention group
Group type: EXPERIMENTAL
Intervention: Telepsychiatry/telepsychology-enhanced referral (TER)
Number of subjects: 1004
Study 34431972 — intervention group
Group type: COMPARATOR
Intervention: Phone-enhanced referral (PER)
Number of subjects: 1004
Study 34431972 — intervention group
Group type: COMPARATOR
Intervention: TCC
Number of subjects: 1004
Study 85052396 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary biliary cirrhosis
Number of subjects: 318
Study 85052396 — intervention group
Group type: COMPARATOR
Intervention: Primary sclerosing cholangitis
Number of subjects: 318
Study 34965774 — intervention group
Group type: EXPERIMENTAL
Intervention: Expanded Disability Status Scale (EDSS)
Number of subjects: 889
Study 34965774 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed 25 Foot Walk (T25FW)
Number of subjects: 889
Study 34965774 — intervention group
Group type: EXPERIMENTAL
Intervention: Nine Hole Peg Test (NHPT)
Number of subjects: 889
Study 34965774 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbol Digit Modalities Test (SDMT)
Number of subjects: 889
Study 34965774 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesional and volumetric imaging outcomes
Number of subjects: 889
Study 34965774 — intervention group
Group type: EXPERIMENTAL
Intervention: 36‐Item Short Form Health Survey (SF‐36)
Number of subjects: 889
Study 34965774 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Sclerosis Impact Scale (MSIS‐29)
Number of subjects: 889
Study 35729038 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-acting antiviral agents (DAAs) treatment
Number of subjects: 21
Study 34315413 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (25 µg)
Number of subjects: 120
Study 34315413 — intervention group
Group type: COMPARATOR
Intervention: Intracervical Foley catheter (FC)
Number of subjects: 120
Study 35329051 — intervention group
Group type: COMPARATOR
Intervention: simple without cues
Number of subjects: 80
Study 35329051 — intervention group
Group type: EXPERIMENTAL
Intervention: simple with cues
Number of subjects: 80
Study 35329051 — intervention group
Group type: COMPARATOR
Intervention: complex without cues
Number of subjects: 80
Study 35329051 — intervention group
Group type: EXPERIMENTAL
Intervention: complex with cues
Number of subjects: 80
Study 32295509 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 7213
Study 32295509 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 7213
Study 34014988 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial thrombolysis (IA-thrombolysis)
Number of subjects: 1497
Study 34014988 — intervention group
Group type: COMPARATOR
Intervention: Mechanical thrombectomy alone
Number of subjects: 1497
Study 34014988 — intervention group
Group type: COMPARATOR
Intervention: Endovascular therapy (EVT)
Number of subjects: 1497
Study 36318623 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized nutrition diet (n=14)
Number of subjects: 25
Study 36318623 — intervention group
Group type: COMPARATOR
Intervention: Standard IBS diet (n=11)
Number of subjects: 25
Study 33502287 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessments and predictions
Number of subjects: 128
Study 33502287 — intervention group
Group type: EXPERIMENTAL
Intervention: Formative exams
Number of subjects: 128
Study 33502287 — intervention group
Group type: EXPERIMENTAL
Intervention: Response rate of 20%
Number of subjects: 128
Study 33502287 — intervention group
Group type: COMPARATOR
Intervention: Female students
Number of subjects: 128
Study 35925913 — intervention group
Group type: EXPERIMENTAL
Intervention: Children instructed to construct the selected idea into a tangible product
Number of subjects: 403
Study 35925913 — intervention group
Group type: COMPARATOR
Intervention: Control group (children informed they had to perform another task after idea selection)
Number of subjects: 403
Study 33398870 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided modified thoracolumbar interfascial plane (mTLIP) block
Number of subjects: 60
Study 35871120 — intervention group
Group type: EXPERIMENTAL
Intervention: HNLP (High Nitrate Low Phenolic) - 50g of lettuce containing 530mg nitrate and 11mg phenolic compounds
Number of subjects: 19
Study 35871120 — intervention group
Group type: COMPARATOR
Intervention: LNHP (Low Nitrate High Phenolic) - 50g of lettuce containing 3mg nitrate and 77mg phenolic compounds
Number of subjects: 19
Study 34670954 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal calprotectin levels in African American infants
Number of subjects: 124
Study 34670954 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal calprotectin levels in infants with private insurance coverage
Number of subjects: 124
Study 34670954 — intervention group
Group type: EXPERIMENTAL
Intervention: S100A12 levels
Number of subjects: 124
Study 33964383 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip arthroscopy (CPT code 29914)
Number of subjects: 35966
Study 33394979 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural Therapy (NT) including local-segmental treatment (intradermal injections) on the lumbosacral region, 5M injection, pelvic plexus injection, i.v. injection (2 mL) for five sessions per week; interference field injections at the first session.
Number of subjects: 50
Study 33394979 — intervention group
Group type: COMPARATOR
Intervention: Single Trigger Point Injection (TPI)
Number of subjects: 50
Study 35380689 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 0
Study 33499848 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous TXA (15 mg/kg in 100 mL of saline solution) administered 10 min before tourniquet release
Number of subjects: 120
Study 33499848 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular TXA (15 mg/kg in 100 mL of saline solution) injected via drainage tube
Number of subjects: 120
Study 33499848 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equivalent volume of normal saline administered into the knee joint cavity and intravenously)
Number of subjects: 120
Study 32285590 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative Mediterranean Diet (aMED) tertile 3
Number of subjects: 7756
Study 32285590 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher fish intake
Number of subjects: 7756
Study 35986947 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine injection (5 g/L Met + 7.5 g/L NaCl)
Number of subjects: 600
Study 35986947 — intervention group
Group type: EXPERIMENTAL
Intervention: Disaccharide injection (25 g/L maltose + 25 g/L sucrose + 7.5 g/L NaCl)
Number of subjects: 600
Study 35986947 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine plus Disaccharide injection (25 g/L maltose + 25 g/L sucrose + 5 g/L Met + 7.5 g/L NaCl)
Number of subjects: 600
Study 35986947 — intervention group
Group type: COMPARATOR
Intervention: Non-injection (control group)
Number of subjects: 600
Study 34233152 — intervention group
Group type: EXPERIMENTAL
Intervention: Finite Difference Method (FDM) for modeling tablet disintegration
Number of subjects: 0
Study 34233152 — intervention group
Group type: EXPERIMENTAL
Intervention: FDM
Number of subjects: 0
Study 34469801 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconditional incentives ($20 gift card)
Number of subjects: 0
Study 34469801 — intervention group
Group type: COMPARATOR
Intervention: Conditional incentives ($20 gift card)
Number of subjects: 0
Study 33268325 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal insufflation (HFNI) at 120 L/min
Number of subjects: 40
Study 33268325 — intervention group
Group type: COMPARATOR
Intervention: Standard flow oxygen insufflation at 10 L/min
Number of subjects: 40
Study 33268325 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal insufflation (HFNI)
Number of subjects: 40
Study 33268325 — intervention group
Group type: COMPARATOR
Intervention: Standard flow oxygen insufflation
Number of subjects: 40
Study 32209645 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM)
Number of subjects: 200
Study 32209645 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin pumps
Number of subjects: 200
Study 32209645 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with LGA infants
Number of subjects: 200
Study 32209645 — intervention group
Group type: COMPARATOR
Intervention: Standard summary metrics
Number of subjects: 200
Study 36110039 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen
Number of subjects: 199
Study 36110039 — intervention group
Group type: COMPARATOR
Intervention: Facemask
Number of subjects: 199
Study 35057457 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g prunes
Number of subjects: 35
Study 35057457 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g prunes
Number of subjects: 35
Study 35057457 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 35
Study 32604121 — intervention group
Group type: EXPERIMENTAL
Intervention: Lu-DOTATATE (median cumulative dose of 27 GBq, range 13.3-41.3 GBq, over 2-7 cycles) and 1250 mg/m capecitabine from days 0 to 14 of each PRRT cycle
Number of subjects: 45
Study 35719637 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab combined with temozolomide + irinotecan (T+I+B)
Number of subjects: 0
Study 35719637 — intervention group
Group type: COMPARATOR
Intervention: Two-agent chemotherapy regimen (T+I)
Number of subjects: 0
Study 35719637 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis
Number of subjects: 0
Study 33570654 — intervention group
Group type: EXPERIMENTAL
Intervention: Luspatercept
Number of subjects: 336
Study 33570654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 336
Study 32560436 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein supplementation
Number of subjects: 104
Study 32560436 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 104
Study 35419898 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented Reality (AR) tool
Number of subjects: 33
Study 35419898 — intervention group
Group type: EXPERIMENTAL
Intervention: Online tool
Number of subjects: 33
Study 35419898 — intervention group
Group type: COMPARATOR
Intervention: Infographic tool (Control)
Number of subjects: 33
Study 33755581 — intervention group
Group type: EXPERIMENTAL
Intervention: Poultry ownership
Number of subjects: 118
Study 33755581 — intervention group
Group type: COMPARATOR
Intervention: No poultry ownership (Control)
Number of subjects: 118
Study 34896233 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitators to uptake of core outcome sets (COS)
Number of subjects: 13
Study 34896233 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to uptake of core outcome sets (COS)
Number of subjects: 13
Study 34959951 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium gluconate supplementation (1000 mg/day added to a basal diet of 2300 mg/day)
Number of subjects: 30
Study 34959951 — intervention group
Group type: COMPARATOR
Intervention: Control (basal diet of 2300 mg/day potassium)
Number of subjects: 30
Study 34959951 — intervention group
Group type: EXPERIMENTAL
Intervention: Potato sources (1000 mg/day added to a basal diet of 2300 mg/day)
Number of subjects: 30
Study 34959951 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium gluconate supplementation
Number of subjects: 30
Study 35030036 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib 560 mg once daily and rituximab 375 mg/m2 (total of eight doses)
Number of subjects: 50
Study 34828781 — intervention group
Group type: EXPERIMENTAL
Intervention: BEMPU TempWatch
Number of subjects: 75
Study 34828781 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 75
Study 35656793 — intervention group
Group type: EXPERIMENTAL
Intervention: Alopecia Areata Symptom Impact Scale (AASIS)
Number of subjects: 0
Study 35656793 — intervention group
Group type: EXPERIMENTAL
Intervention: Alopecia Areata Quality of Life Index (AA‐QLI)
Number of subjects: 0
Study 35656793 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with dupilumab
Number of subjects: 0
Study 35656793 — intervention group
Group type: EXPERIMENTAL
Intervention: AASIS
Number of subjects: 0
Study 35656793 — intervention group
Group type: EXPERIMENTAL
Intervention: SALT score ≤ 20
Number of subjects: 0
Study 32752021 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutri-Score
Number of subjects: 1032
Study 32752021 — intervention group
Group type: COMPARATOR
Intervention: Reference intakes
Number of subjects: 1032
Study 32752021 — intervention group
Group type: COMPARATOR
Intervention: Health Star Rating system
Number of subjects: 1032
Study 32752021 — intervention group
Group type: COMPARATOR
Intervention: Multiple traffic lights
Number of subjects: 1032
Study 32752021 — intervention group
Group type: COMPARATOR
Intervention: Warning symbol
Number of subjects: 1032
Study 35388606 — intervention group
Group type: COMPARATOR
Intervention: Oral isotretinoin (0.5 mg/kg once daily for 16 weeks) + SM peeling (20% salicylic and 10% mandelic acid every four weeks for 16 weeks)
Number of subjects: 58
Study 32623812 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (monthly for 2 years)
Number of subjects: 413
Study 32623812 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (monthly for 2 years)
Number of subjects: 413
Study 32623812 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintaining sufficient vitamin D levels (n = 226)
Number of subjects: 413
Study 32623812 — intervention group
Group type: COMPARATOR
Intervention: Not maintaining sufficient vitamin D levels (n = 114)
Number of subjects: 413
Study 32168433 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-hydroxytryptophan (5-HTP)
Number of subjects: 0
Study 35145675 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid sacrificing group
Number of subjects: 100
Study 35145675 — intervention group
Group type: COMPARATOR
Intervention: Thyroid sparing group
Number of subjects: 100
Study 32203933 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle power training (PT) session
Number of subjects: 13
Study 32203933 — intervention group
Group type: COMPARATOR
Intervention: Control session without exercise
Number of subjects: 13
Study 33386338 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral water‐soluble vitamin A (5000 IU per day)
Number of subjects: 188
Study 33386338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study 33386338 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral water‐soluble vitamin A
Number of subjects: 188
Study 33235285 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (125 mg)
Number of subjects: 18
Study 33235285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 34217854 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-supervised Non-Parametric Instance Discrimination (NPID)
Number of subjects: 4757
Study 34217854 — intervention group
Group type: COMPARATOR
Intervention: Supervised-trained networks
Number of subjects: 4757
Study 34217854 — intervention group
Group type: COMPARATOR
Intervention: Human ophthalmologists
Number of subjects: 4757
Study 34036557 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest algorithm using 13 SNPs (ANRIL, HOTAIR, IL‐6, IL‐8)
Number of subjects: 400
Study 34763652 — intervention group
Group type: EXPERIMENTAL
Intervention: Training intervention based on the transactional model, consisting of 6 training sessions.
Number of subjects: 116
Study 34763652 — intervention group
Group type: EXPERIMENTAL
Intervention: Training intervention based on the transactional model.
Number of subjects: 116
Study 32886566 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter only outreach
Number of subjects: 2626
Study 32886566 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter and telephone call outreach
Number of subjects: 2626
Study 32886566 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter, text message, and telephone call outreach
Number of subjects: 2626
Study 32886566 — intervention group
Group type: COMPARATOR
Intervention: Control group (no outreach)
Number of subjects: 2626
Study 34715537 — intervention group
Group type: COMPARATOR
Intervention: Virtual bedside teaching
Number of subjects: 0
Study 34715537 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person bedside teaching
Number of subjects: 0
Study 33313936 — intervention group
Group type: EXPERIMENTAL
Intervention: Daylight photodynamic therapy (5 full-face sessions over 2 years)
Number of subjects: 58
Study 33313936 — intervention group
Group type: COMPARATOR
Intervention: Cryosurgery (lesion-directed)
Number of subjects: 58
Study 33313936 — intervention group
Group type: EXPERIMENTAL
Intervention: Daylight photodynamic therapy
Number of subjects: 58
Study 34853156 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BRJ) (12.9 mmol nitrate)
Number of subjects: 20
Study 34853156 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nitrate-depleted BRJ)
Number of subjects: 20
Study 32195858 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical video
Number of subjects: 22
Study 32195858 — intervention group
Group type: COMPARATOR
Intervention: Text-based materials alone
Number of subjects: 22
Study 36444695 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice from prognostic algorithm (PiPS-B14)
Number of subjects: 283
Study 36444695 — intervention group
Group type: COMPARATOR
Intervention: Advice from another clinician
Number of subjects: 283
Study 36444695 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice of intermediate strength (75%)
Number of subjects: 283
Study 36444695 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice received at 50% strength
Number of subjects: 283
Study 36444695 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice received at 90% strength
Number of subjects: 283
Study 33037795 — intervention group
Group type: EXPERIMENTAL
Intervention: Osseodensification (OD)
Number of subjects: 30
Study 33037795 — intervention group
Group type: COMPARATOR
Intervention: Under Drilling (UD)
Number of subjects: 30
Study 36131630 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC) for 60 min before and after the procedure
Number of subjects: 80
Study 36131630 — intervention group
Group type: COMPARATOR
Intervention: No-KMC (control)
Number of subjects: 80
Study 33485635 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined bilirubin
Number of subjects: 331002
Study 35501091 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port insufflation endoscopic nipple-sparing mastectomy (SIE-NSM)
Number of subjects: 0
Study 35501091 — intervention group
Group type: COMPARATOR
Intervention: Conventional open mastectomy (C-OM)
Number of subjects: 0
Study 33884979 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 40
Study 33884979 — intervention group
Group type: COMPARATOR
Intervention: Milrinone
Number of subjects: 40
Study 36424554 — intervention group
Group type: EXPERIMENTAL
Intervention: Left nostril (Group L, n=25)
Number of subjects: 50
Study 36424554 — intervention group
Group type: COMPARATOR
Intervention: Right nostril (Group R, n=25)
Number of subjects: 50
Study 36424554 — intervention group
Group type: EXPERIMENTAL
Intervention: Left nostril (Group L)
Number of subjects: 50
Study 36424554 — intervention group
Group type: COMPARATOR
Intervention: Right nostril (Group R)
Number of subjects: 50
Study 36424554 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 34679404 — intervention group
Group type: EXPERIMENTAL
Intervention: M-Pharm/ECT (pharmacotherapy plus maintenance ECT)
Number of subjects: 37
Study 34679404 — intervention group
Group type: COMPARATOR
Intervention: M-Pharm (pharmacotherapy alone)
Number of subjects: 37
Study 34679404 — intervention group
Group type: COMPARATOR
Intervention: M-Pharm/ECT and M-Pharm
Number of subjects: 37
Study 33451057 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.6 g of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) per day (0.3 g EPA and 1.3 g DHA) in a microencapsulated powder
Number of subjects: 78
Study 33451057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 32516769 — intervention group
Group type: EXPERIMENTAL
Intervention: 550 ppm F dentifrice (pea size or transversal technique)
Number of subjects: 18
Study 32516769 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,100 ppm F dentifrice (pea size)
Number of subjects: 18
Study 32516769 — intervention group
Group type: EXPERIMENTAL
Intervention: 550 ppm F dentifrice (transversal technique)
Number of subjects: 18
Study 35820739 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular-based psychotherapy (MoBa)
Number of subjects: 70
Study 35820739 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 70
Study 32694001 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical exercise (60 minutes twice a week for 24 months)
Number of subjects: 299
Study 32694001 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical exercise
Number of subjects: 299
Study 33346748 — intervention group
Group type: EXPERIMENTAL
Intervention: Choral Singing Intervention (CSI)
Number of subjects: 93
Study 33346748 — intervention group
Group type: COMPARATOR
Intervention: Health Education Program (HEP)
Number of subjects: 93
Study 33346748 — intervention group
Group type: COMPARATOR
Intervention: Between-group comparison
Number of subjects: 93
Study 34131267 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA (3.0 g/day) for 12 weeks
Number of subjects: 22
Study 34131267 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (1.4 g/day) for 12 weeks
Number of subjects: 22